Search images on Google      Product Monograph

Active Ingredients:

• ranibizumab, 10 MG/ML

DIN: 02525852

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVITREAL

Description: SINGLE USE VIALS

Schedule: Prescription

Company: SAMSUNG BIOEPIS CO., LTD

ATC:

• S01 - OPHTHALMOLOGICALS (ATC, WHO, Wiki)
• S01L - OCULAR VASCULAR DISORDER AGENTS (ATC, WHO)
• S01LA - Antineovascularisation agents (ATC, WHO)
• S01LA04 - RANIBIZUMAB (WHO)

Reference brand drug: Lucentis

 

External Links for Byooviz:

Search on Google

• Byooviz side effects
• Byooviz dosage
• ranibizumab side effects
• ranibizumab dosage